They tend to subside as your body adjusts
Tirzepatide Side Effects# Well-characterized from Phase 3 (SURPASS, SURMOUNT) trials and post-market surveillance: Gastrointestinal : Nausea (12-33%), diarrhea (12-21%), vomiting (5-12%), constipation (6-11%) Decreased appetite : Common and expected pharmacological effect Injection site reactions : Mild, occurring in 2-5% of patients Pancreatitis : Rare
Mounjaro is more costly but more effective than Ozempic in controlling blood sugar levels and weight loss but may have additional side effects
When combined with careful attention to Vitamin B12 status, patients can experience enhanced benefits while minimizing potential risks
Microdosing Tirzepatide has shown promise in supporting longevity by optimizing metabolism, improving blood sugar regulation, enhancing cardiovascular health, and promoting cellular function